HR7653119th Congress

Biodefense Diplomacy Enhancement Act

Sponsored By: Representative Self

Introduced

Summary

Strengthens U.S. diplomacy to coordinate international biodefense, biosecurity, and biotechnology cooperation. It would push the State Department to lead NATO and partner diplomacy to close gaps in planning, standards, and response to biological threats.

Show full summary
  • Would push NATO to prioritize biodefense policy and improve planning, interoperability, and allied capabilities for detection, attribution, emergency response, and recovery.
  • Would seek cooperation with major non-NATO allies and coordinate export controls for dual-use biotechnology items that pose national security risks.
  • Would promote higher safety and security standards for biological research and explore expanding allied research and development for biodefense purposes.
  • Would require two strategies for Congress: a NATO Biodefense Strategy and an International Biotechnology, Biosecurity, and Biodefense Cooperation Strategy, with the report due in 270 days and a briefing due in 90 days.

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Stronger NATO and global biodefense ties

If enacted, the Secretary of State would lead new diplomatic work on biodefense, biosecurity, and biotechnology. The Secretary would write two strategies: a NATO Biodefense Strategy and an International Biotechnology, Biosecurity, and Biodefense Cooperation Strategy. The NATO plan would assess U.S.–NATO cooperation, find gaps, and recommend steps to improve detection, response, and allied interoperability. The international plan would propose cooperation with allies (including major non‑NATO allies), study coordinating export controls beyond existing regimes, and recommend use of State Department and NADR funds. The Secretary would send the unclassified strategies to the House Foreign Affairs and Senate Foreign Relations Committees within 270 days, with an optional classified annex, and provide a briefing within 90 days. The strategies would be limited to threats from biological agents and toxins as defined in federal law.

Sponsors & CoSponsors

Sponsor

Self

TX • R

Cosponsors

  • Keating

    MA • D

    Sponsored 2/23/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov

Related Bills

Back to Legislation

Take It Personal

Get Your Personalized Policy View

Create a free account to save research, track policy impacts, and unlock your personalized versions of these pages.

Already have an account? Sign in